US0042251084
US0042251084
ACADIA Pharmaceuticals Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.071.505.000 | 957.797.000 | 11.9% |
| Cost of Revenue | 88.998.000 | 81.841.000 | 8.7% |
| Gross Profit | 982.507.000 | 875.956.000 | 12.2% |
| 877.696.000 | 791.677.000 | 10.9% | |
| Operating Income | 104.811.000 | 84.279.000 | 24.4% |
| Pretax Income | 138.904.000 | 258.075.000 | 46.2% |
| Net Income Common Stockholders | 391.000.000 | 226.451.000 | 72.7% |
| -- | -- | -- | |
| -- | -- | -- |